NewsBenzinga모건 스탠리, 킨더 모건 투자의견 ‘동등 비중’ 유지···목표주가 39달러로 하향 모건 스탠리, 킨더 모건 투자의견 ‘동등 비중’ 유지···목표주가 39달러로 하향 Benzinga 2026.11.03 17:37 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $760 Citigroup Maintains Neutral on LyondellBasell Industries, Raises Price Target to $74 SpaceX Partners With Air Tahiti Nui To Equip Entire Fleet With Free Starlink Wi-Fi 'Meta Draws $58 Billion Demand for US Leg of Cross-Border Bond' - Bloomberg News Citigroup Maintains Neutral on FMC, Raises Price Target to $7 Citigroup Maintains Buy on Eastman Chemical, Lowers Price Target to $75
